Empowering Healthcare Transformation Across Europe with Enhanced Virtual Care Solutions

We’re excited to announce that Doccla has successfully closed a £35 million Series B funding round. This marks a significant milestone for us as we continue our mission to revolutionise healthcare delivery through virtual wards and remote patient monitoring.

Our Vision for Growth: Expanding Across Europe

Since 2019, we have been dedicated to supporting the NHS with our fully managed virtual ward services, monitoring over 4 million patient days across nearly half of the NHS regions. Our solutions have demonstrated substantial cost savings, reduced emergency admissions, and improved patient outcomes. But this is just the beginning.

With this new funding, led by Lakestar and joined by Elaia, General Catalyst, Bertelsmann Investments, and Speedinvest, we are ready to take the next step: expanding further into Europe. We are particularly excited to extend our presence in France and the DACH region (Germany, Austria, and Switzerland), where there is a tremendous opportunity to bring our innovative, cost-effective healthcare solutions to a wider audience. These markets represent a combined opportunity of over £11 billion, and we are confident that our technology and expertise will make a significant impact.

‍

Doccla Founder Martin Ratz comments: “Doccla was founded to provide hospital-level care and support at home for multiple patient profiles across the acuity spectrum: enabling the early discharge of patients, as well as ensuring that for those with chronic care needs, hospital admission might be avoided in the first place. Technology-enabled virtual wards deliver great benefits for patients, who can recover at home, while freeing up resources for healthcare providers. Our work has proven immensely valuable to the UK’s National Health Service and we’re excited to scale our European operations. At the same time, we see exceptional upside potential for our services in the Life Sciences sector, and will continue to invest in our data science operations.”

‍

Lakestar Partner and new Doccla board member Oliver Heimes comments: “In less than five years Doccla has gone from a research project to establishing itself as the market leader in the UK. We are confident they will not just maintain that position but successfully launch in new markets, whilst diversifying their services. Remote patient care delivers proven results and is ushering in new standards in the healthcare systems globally.”

‍

Strengthening Our Role in Life Sciences

We are also expanding our presence in the Life Sciences sector. By leveraging our virtual care solutions, we aim to provide critical real-world evidence and support for pharmaceutical companies, improving therapeutic outcomes and patient safety. Our investment in data science and new technologies will enable us to continue enhancing patient care and developing next-generation treatments.

Delivering Proven Results

Our achievements to date have been transformative for healthcare providers and patients alike. Our technology-enabled virtual wards have already led to a 63% reduction in A&E attendance and delivered a 300% return on investment for our NHS partners. We have been able to achieve these results through our 24/7 patient monitoring and real-time data analytics, allowing healthcare professionals to intervene early and effectively, reducing emergency admissions and improving patient experiences.

Our 100% client retention rate in the UK reflects the trust and satisfaction our services inspire among patients and clinical staff. As we expand into new markets, we are committed to maintaining these high standards of care and support, ensuring the same level of success across Europe.

Looking Ahead: A New Chapter for Doccla

This funding round is a testament to our vision and the confidence our investors and partners have in us. With their support, we are more determined than ever to lead the transformation of healthcare delivery across Europe. We are eager to scale our operations and bring our virtual wards to more people, offering a flexible and scalable solution that meets the diverse needs of different healthcare markets.

Thank you to everyone—our investors, partners, clients, and team—who has supported us on this journey. We are just getting started, and we are excited to see what the future holds.

‍

For more information about our mission and vision, visit Doccla.com.

‍

Stay tuned for more updates as we continue to grow and innovate in the digital health landscape.